Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for MediciNova, Inc. (MNOV)

« Back to company index

MNOV Chatter Timeline

Stock Ticker for MNOV

Most Active Tweeters for MNOV

UserTweets
@bulletin_en 5
@UlmHi 3
@thefinreviewer 3
@mmahotstuff1 3
@ContentCarnivor 2

Recent Tweets for MNOV

ZolmaxNews @ZolmaxNews
Brokerages Expect MediciNova, Inc. $MNOV to Post -$0.14 Earnings Per Share https://t.co/WOtqefirnu
April 19th 2019, 6:04pm
TickerReport @TickerReport
MediciNova, Inc. $MNOV Given Consensus Recommendation of “Strong Buy” by Brokerages https://t.co/CoEhaYiy7E
April 19th 2019, 6:04pm
BlogYomi @BlogYomi
bluebird bio Inc. $MNOV Comparing side by side https://t.co/Pk92XZW10q
April 17th 2019, 7:04pm
bulletin_en @bulletin_en
Medicinova Inc $MNOV Sellers Declined By 0.61% Their Shorts As Of Apr 17, 2019 https://t.co/J7N6wJ73q4
April 17th 2019, 4:04pm
UlmHi @UlmHi
Reviewing Asterias Biotherapeutics Inc. $MNOV's results https://t.co/uw2gRzJfw9
April 17th 2019, 2:04pm
thefinreviewer @thefinreviewer
Comparing of Cara Therapeutics Inc. $MNOV https://t.co/KMF3oPvWEO
April 16th 2019, 9:04pm
mmahotstuff1 @mmahotstuff1
Medicinova Inc $MNOV Shorts Decreased by 0.61% After Short Covering https://t.co/03d5IY76io
April 16th 2019, 11:04am
vitalhongkong @vitalhongkong
RT @MarketCurrents: $MNOV - MediciNova on go with pivotal study of MN-166 in ALS https://t.co/NLRjghgFRv
April 16th 2019, 9:04am
Briefingcom @Briefingcom
$MNOV: MediciNova receives approval from FDA to proceed with Phase 3 Trial of MN-166 https://t.co/3Ouvd6GquO
April 16th 2019, 8:04am
NewsToDesk @NewsToDesk
$MNOV: MediciNova on go with pivotal study of MN-166 in ALS: https://t.co/B9DmWsD5K4
April 16th 2019, 7:04am
MarketCurrents @MarketCurrents
$MNOV - MediciNova on go with pivotal study of MN-166 in ALS https://t.co/NLRjghgFRv
April 16th 2019, 7:04am
bulletin_en @bulletin_en
Intellia Therapeutics Inc. $MNOV Contrasting side by side https://t.co/kxRHGb4I0J
April 15th 2019, 10:04pm
thefinreviewer @thefinreviewer
Reviewing Nightstar Therapeutics plc $MNOV's results https://t.co/aoB3ba9Dgw
April 15th 2019, 8:04pm
HottestStockNow @HottestStockNow
$MNOV Reveals Plans to Move Forward with a Late-Stage Trial of MN-166 (ibudilast) in amyotrophic lateral sclerosis https://t.co/k5ZDOXvag2
April 15th 2019, 8:04pm
Allstocknews @Allstocknews
$MNOV MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS From our Stock News Alerts App
April 15th 2019, 7:04pm
UlmHi @UlmHi
Rhythm Pharmaceuticals Inc. $MNOV Comparison side by side https://t.co/lRhcGwCc2O
April 15th 2019, 4:04pm
bulletin_en @bulletin_en
Medicinova Inc $MNOV Move as Big Money' Sentiment Increased to 1.69 https://t.co/kRCt97puFq
April 15th 2019, 1:04pm
ContentCarnivor @ContentCarnivor
$MNOV Subset Analysis Shows MS Treatment Highly Effective https://t.co/hQhQIDQdSH $MNOV @davidbautz #biotech #ALS https://t.co/79PuWjoQ3S
April 15th 2019, 10:04am
stocknewstimes @stocknewstimes
MediciNova, Inc. $MNOV Given $19.67 Consensus Target Price by Analysts https://t.co/nQlYecvOxo
April 15th 2019, 7:04am
TheMarketsDaily @TheMarketsDaily
MediciNova, Inc. $MNOV Receives Consensus Recommendation of “Strong Buy” from Brokerages https://t.co/wr7XsfekeV
April 15th 2019, 7:04am
bulletin_en @bulletin_en
MediciNova $MNOV Upgraded By BidaskScore; Cipher Capital LP Boosted Its Check Point Software Tech Lt $CHKP Stake https://t.co/FVeorkGDqq
April 15th 2019, 5:04am
mmahotstuff1 @mmahotstuff1
Should Investors Turn Their Attention to MediciNova $MNOV? BidaskScore Upgrades Shares https://t.co/dClDfqiL5p
April 15th 2019, 12:04am
whatsonthorold2 @whatsonthorold2
Is MediciNova $MNOV now a ‘Buy’ After a BidaskScore Upgrade? https://t.co/13vUQXnAwF
April 15th 2019, 12:04am
bibeypost_stock @bibeypost_stock
MediciNova $MNOV Now a Buy? BidaskScore Has Upgraded The Stock https://t.co/4uoxQ8PkOE
April 15th 2019, 12:04am
reurope_stock @reurope_stock
MediciNova $MNOV Stock May Be About to Breakout After BidaskScore Upgrades Shares https://t.co/jaMJiEIvzG
April 15th 2019, 12:04am
risk_averse_ @risk_averse_
$MNOV Subset Analysis Shows MS Treatment Highly Effective https://t.co/ceVTmQ703B $MNOV @davidbautz #biotech #ALS https://t.co/KoklU6ODv0
April 14th 2019, 6:04pm
AnalystsAnalyst @AnalystsAnalyst
$MNOV Subset Analysis Shows MS Treatment Highly Effective https://t.co/rNIAsZJlnO $MNOV @davidbautz #biotech #ALS https://t.co/31Dsi9H3L1
April 14th 2019, 4:04pm
ContentCarnivor @ContentCarnivor
$MNOV Progressive MS Therapy Moving to Phase 3 Trial https://t.co/xfsNiySkQ1 $MNOV @davidbautz #biotech #ALS https://t.co/T170LQFQQV
April 14th 2019, 3:04pm
risk_averse_ @risk_averse_
$MNOV Progressive MS Therapy Moving to Phase 3 Trial https://t.co/yUxy6JqbqC $MNOV @davidbautz #biotech #ALS https://t.co/6y8FsiO11U
April 14th 2019, 1:04pm
AnalystsAnalyst @AnalystsAnalyst
$MNOV Progressive MS Therapy Moving to Phase 3 Trial https://t.co/MsNp6qxM9R $MNOV @davidbautz #biotech #ALS https://t.co/MvhjZyOtOy
April 14th 2019, 11:04am
ahighelevation @ahighelevation
$MNOV Subset Analysis Shows MS Treatment Highly Effective https://t.co/WmX8aSEKHu $MNOV @davidbautz #biotech #ALS https://t.co/p58QD359UX
April 14th 2019, 3:04am
thefinreviewer @thefinreviewer
Reviewing Immuron Limited $MNOV's results https://t.co/ZDdU8DCq2A
April 13th 2019, 8:04pm
ahighelevation @ahighelevation
$MNOV Progressive MS Therapy Moving to Phase 3 Trial https://t.co/ubYE3ChD0C $MNOV @davidbautz #biotech #ALS https://t.co/huCk9OqVN7
April 13th 2019, 4:04pm
ZacksAwareness @ZacksAwareness
$MNOV Subset Analysis Shows MS Treatment Highly Effective https://t.co/1n5ug4Ioc7 $MNOV @davidbautz #biotech #ALS https://t.co/H3UONg8GFH
April 13th 2019, 11:04am
tzack16 @tzack16
$MNOV Subset Analysis Shows MS Treatment Highly Effective https://t.co/kIOA1l42HR $MNOV @davidbautz #biotech #ALS https://t.co/3fmcCN3xY3
April 13th 2019, 11:04am
UlmHi @UlmHi
Benjamin F Edwards & Company Has Trimmed Its Deere & Co $DE Holding; Medicinova $MNOV's Sentiment Is 1.69 https://t.co/NtfsljhxrJ
April 13th 2019, 11:04am
tzack16 @tzack16
$MNOV Progressive MS Therapy Moving to Phase 3 Trial https://t.co/BXLe9ttGXg $MNOV @davidbautz #biotech #ALS https://t.co/Nf7LjWncBS
April 13th 2019, 12:04am
ZacksAwareness @ZacksAwareness
$MNOV Progressive MS Therapy Moving to Phase 3 Trial https://t.co/72lhQmqn5P $MNOV @davidbautz #biotech #ALS https://t.co/7eiU4MxG9d
April 12th 2019, 3:04pm
bulletin_en @bulletin_en
Medicinova Inc $MNOV Shorts Decreased By 0.61% As Of Apr 12, 2019 https://t.co/Dmdb5kIWmz
April 12th 2019, 3:04pm
dispatchtribune @dispatchtribune
MediciNova, Inc. $MNOV Given $19.67 Consensus Price Target by Analysts https://t.co/idVzbtkQoP
April 12th 2019, 12:04pm
AmericanBanking @AmericanBanking
MediciNova, Inc. $MNOV Given $19.67 Consensus Price Target by Analysts https://t.co/i72RUXQjal #stocks
April 12th 2019, 12:04pm
OlympiaReport @OlympiaReport
MediciNova, Inc. $MNOV Given $19.67 Consensus Price Target by Brokerages https://t.co/jLo5hNQOKA
April 12th 2019, 12:04pm
dailypoliticaln @dailypoliticaln
MediciNova $MNOV Stock Rating Upgraded by BidaskClub https://t.co/zlJ3OVGARq
April 12th 2019, 9:04am
TickerReport @TickerReport
MediciNova $MNOV Lifted to “Sell” at BidaskClub https://t.co/gHmjV7lwkk
April 12th 2019, 9:04am
zackcappsocial @zackcappsocial
$MNOV Subset Analysis Shows MS Treatment Highly Effective https://t.co/WyAEejNSQq $MNOV @davidbautz #biotech #ALS https://t.co/eoMmFhqfj4
April 12th 2019, 8:04am
TheTruthStudio @TheTruthStudio
$MNOV Subset Analysis Shows MS Treatment Highly Effective https://t.co/bTnvXCTytK $MNOV @davidbautz #biotech #ALS https://t.co/Lf8Qaio4F7
April 11th 2019, 5:04pm
InstitutionalZC @InstitutionalZC
$MNOV Subset Analysis Shows MS Treatment Highly Effective https://t.co/ewpGhzSy0s $MNOV @davidbautz #biotech #ALS https://t.co/a46CeN4VNp
April 11th 2019, 4:04pm
zackcappsocial @zackcappsocial
$MNOV Progressive MS Therapy Moving to Phase 3 Trial https://t.co/Kyrpah5cJe $MNOV @davidbautz #biotech #ALS https://t.co/lV0eGS3RHr
April 11th 2019, 3:04pm
HowieRegay @HowieRegay
$MNOV Subset Analysis Shows MS Treatment Highly Effective https://t.co/tuIqeFHhJe $MNOV @davidbautz #biotech #ALS https://t.co/vjGF9MfXOV
April 11th 2019, 3:04pm
zackcapp @zackcapp
$MNOV Subset Analysis Shows MS Treatment Highly Effective https://t.co/JhTlY6IGJW $MNOV @davidbautz #biotech #ALS https://t.co/zbXSARa2WC
April 11th 2019, 3:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.